Non-arteritic anterior ischemic optic neuropathy, PDE-5 inhibitors, and amiodarone: may there be a sex hormone effect for the eye?
Verit
A
A
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000638:Amiodarone / Q000009:adverse effects / Q000494:pharmacology*; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D005123:Eye / Q000098:blood supply* / Q000187:drug effects; D012739:Gonadal Steroid Hormones / Q000502:physiology*; D006801:Humans; D018917:Optic Neuropathy, Ischemic / Q000139:chemically induced / Q000188:drug therapy* / Q000201:enzymology*; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000009:adverse effects / Q000494:pharmacology*
D012739:Gonadal Steroid Hormones; D010726:Phosphodiesterase Inhibitors; D014665:Vasodilator Agents; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; C517381:PDE5A protein, human; D000638:Amiodarone